Authors:
Liu, XS
Shi, Y
Han, EKH
Chen, ZH
Rosenberg, SH
Giranda, VL
Luo, Y
Ng, SC
Citation: Xs. Liu et al., Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells, NEOPLASIA, 3(4), 2001, pp. 278-286
Authors:
Szczepankiewicz, BG
Liu, G
Jae, HS
Tasker, AS
Gunawardana, IW
von Geldern, TW
Gwaltney, SL
Wu-Wong, JR
Gehrke, L
Chiou, WJ
Credo, RB
Alder, JD
Nukkala, MA
Zielinski, NA
Jarvis, K
Mollison, KW
Frost, DJ
Bauch, JL
Hui, YH
Claiborne, AK
Li, Q
Rosenberg, SH
Citation: Bg. Szczepankiewicz et al., New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models, J MED CHEM, 44(25), 2001, pp. 4416-4430
Authors:
Tahir, SK
Han, EKH
Credo, B
Jae, HS
Pietenpol, JA
Scatena, CD
Wu-Wong, JSR
Frost, D
Sham, H
Rosenberg, SH
Ng, SC
Citation: Sk. Tahir et al., A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors, CANCER RES, 61(14), 2001, pp. 5480-5485
Authors:
Chen, J
Wu, W
Tahir, SK
Kroeger, PE
Rosenberg, SH
Cowsert, LM
Bennett, F
Krajewski, S
Krajewska, M
Welsh, K
Reed, JC
Ng, SC
Citation: J. Chen et al., Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth, NEOPLASIA, 2(3), 2000, pp. 235-241
Authors:
Han, EKH
Gehrke, L
Tahir, SK
Credo, RB
Cherian, SP
Sham, H
Rosenberg, SH
Ng, SC
Citation: Ekh. Han et al., Modulation of drug resistance by alpha-tubulin in paclitaxel-resistant human lung cancer cell lines, EUR J CANC, 36(12), 2000, pp. 1565-1571
Authors:
Augeri, DJ
Janowick, D
Kalvin, D
Sullivan, G
Larsen, J
Dickman, D
Ding, H
Cohen, J
Lee, J
Warner, R
Kovar, P
Cherian, S
Saeed, B
Zhang, HC
Tahir, S
Ng, SC
Sham, H
Rosenberg, SH
Citation: Dj. Augeri et al., Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase, BIOORG MED, 9(8), 1999, pp. 1069-1074
Authors:
Gu, WZ
Tahir, SK
Wang, YC
Zhang, HC
Cherian, SP
O'Connor, S
Leal, JA
Rosenberg, SH
Ng, SC
Citation: Wz. Gu et al., Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in vitro and in vivo, EUR J CANC, 35(9), 1999, pp. 1394-1401
Authors:
Gu, WZ
Chen, ZH
Tahir, SK
Rosenberg, SH
Ng, SC
Citation: Wz. Gu et al., Synergistic effect of paclitaxel and 4-hydroxytamoxifen on estrogen receptor-negative colon cancer and lung cancer cell lines, ANTI-CANC D, 10(10), 1999, pp. 895-901
Authors:
Henry, KJ
Wasicak, J
Tasker, AS
Cohen, J
Ewing, P
Mitten, M
Larsen, JJ
Kalvin, DM
Swenson, R
Ng, SC
Saeed, B
Cherian, S
Sham, H
Rosenberg, SH
Citation: Kj. Henry et al., Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity, J MED CHEM, 42(23), 1999, pp. 4844-4852
Authors:
O'Connor, SJ
Barr, KJ
Wang, L
Sorensen, BK
Tasker, AS
Sham, H
Ng, SC
Cohen, J
Devine, E
Cherian, S
Saeed, B
Zhang, HC
Lee, JY
Warner, R
Tahir, S
Kovar, P
Ewing, P
Alder, J
Mitten, M
Leal, J
Marsh, K
Bauch, J
Hoffman, DJ
Sebti, SM
Rosenberg, SH
Citation: Sj. O'Connor et al., Second-generation peptidomimetic inhibitors of protein farnesyltransferasedemonstrating improved cellular potency and significant in vivo efficacy, J MED CHEM, 42(18), 1999, pp. 3701-3710